Practical Compliance. Real-World Ready.

Medical Devices

Pharmaceuticals

Combination Products

Biologics

Who We Are.

Trusted. Proven. Chosen.

With 20+ years of proven success and a roster of returning clients, QualityHub isn’t just experienced – we are experience, built on trust, results, and lasting relationships. We transform goals into outcomes and foster bonds that stand the test of time.

> Learn More

On-Demand Talent
for the Lifecycle of
Your Regulated Product.

Talent Categories
Product Development/R&D Quality Assurance Regulatory Affairs Manufacturing & Operations Supply Chain Clinical Program/Project Management

Product Development/R&D

When projects pile up and timelines tighten, QualityHub delivers product development and R&D professionals who keep things moving. Our experts plug in fast, bring fresh perspectives, and drive progress without missing a beat.

> Find out how QualityHub has your staffing needs covered for product development and R&D.

Quality Assurance

Need sharp, reliable QA talent – right now? QualityHub connects you with experienced Quality Assurance experts who hit the ground running. From audit prep to process validation, our professionals keep your quality system compliant, efficient, and stress-free.

> Find out how QualityHub has your QA staffing needs covered.

Regulatory Affairs

Regulatory challenges move fast, so make sure your team moves faster. QualityHub matches your company with longtime Regulatory Affairs pros who seamlessly integrate, tackle complex requirements, and keep your projects on track.

> Find out how QualityHub has your RA staffing needs covered.

Manufacturing & Operations

Need skilled manufacturing and operations experts who are ready on Day One? QualityHub delivers top-tier talent fast so you never miss a beat. Whether it’s ramping up production or creatively handling unexpected demands, our experts keep things running smoothly.

> Find out how QualityHub has your staffing needs covered for manufacturing and operations.

Supply Chain

Power your supply chain with seasoned experts who know the ropes and the regulations. At QualityHub, we connect you with top-tier professionals who don’t just understand supply chain challenges – they bring risk management, contingency plans, and resilience.

> Find out how QualityHub has staffing needs covered for your supply chain.

Clinical

QualityHub’s clinical pros understand regulated industry’s need for rigorous clinical data. Our carefully vetted professionals ensure compliance with requirements, appropriate study design, and clear interpretation of results, giving your company market authorization confidence and the highest standards of product quality and safety.

> Find out how QualityHub has your clinical staffing needs covered.

Program/Project Management

QualityHub experts bring clarity, compliance mastery, and relentless focus to the management of your regulated company’s programs and projects. They streamline workflows, minimize risks, and keep initiatives advancing and on target.

> Find out how QualityHub has your staffing needs covered for program and project management.

What Our Clients Say About Us.

"The FDA readiness training was tailored to our specific manufacturing site and incorporated local procedures and previous regulatory comments. This targeted approach yielded a greater training impact and understanding."
"The training we received from QualityHub FDA compliance consultants was invaluable in preparing the site for an inspection. This helped establish proper expectations and confidence. QualityHub provided excellent screening, guidance and training for the establishment of the staging room operations, scribes and inspection administrators."
"QualityHub's input in regard to inspection readiness has been very helpful in preparation for that success!"
"The FDA readiness training by QualityHub is a great refresher course. Take the time to polish up and improve your preparedness knowing their knowledge and expertise makes this a worthwhile practice."
"Thanks to QualityHub's input and the mock inspection, our improved tactics and inspection readiness activities really paid off."

Explore Our MediaHub

MedCon 2026: FDA Official Reminds MedTechs They’re ‘Ultimately Responsible’ for Submitted Data

FDA official Josh Nipper warned medical device companies at MedCon that they remain fully accountable for the accuracy and integrity of all data submitted for regulatory review, even when using third-party testing labs. Data integrity issues trigger immediate negative decisions and have derailed submissions across multiple pathways, often at significant cost. The agency is signaling a stricter regulatory focus on end-to-end data oversight as device complexity continues to grow.

MedCon 2026: FDA Says Medical Device Inspectorate Builds on QSIT Legacy

FDA officials at MedCon 2026 said the agency’s new medical device inspection framework under the Quality Management System Regulation builds on the legacy of the Quality System Inspection Technique while emphasizing more standardized and comprehensive investigator training. They highlighted that training expanded across different FDA centers and has been underway since 2020, aiming to better prepare investigators for practical application and cross-functional oversight.

MedCon 2026: FDA Official Reminds MedTechs They’re ‘Ultimately Responsible’ for Submitted Data

FDA official Josh Nipper warned medical device companies at MedCon that they remain fully accountable for the accuracy and integrity of all data submitted for regulatory review, even when using third-party testing labs. Data integrity issues trigger immediate negative decisions and have derailed submissions across multiple pathways, often at significant cost. The agency is signaling a stricter regulatory focus on end-to-end data oversight as device complexity continues to grow.

MedCon 2026: FDA Says Medical Device Inspectorate Builds on QSIT Legacy

FDA officials at MedCon 2026 said the agency’s new medical device inspection framework under the Quality Management System Regulation builds on the legacy of the Quality System Inspection Technique while emphasizing more standardized and comprehensive investigator training. They highlighted that training expanded across different FDA centers and has been underway since 2020, aiming to better prepare investigators for practical application and cross-functional oversight.

MedCon 2026: FDA Pressed on Review Timelines as Agency Official Acknowledges ‘Strain’

At MedCon 2026, FDA official Barb Marsden acknowledged growing strain on medical device review timelines driven by staffing shortages and MDUFA-related workload pressures, while stakeholders raised concerns about inconsistent deadline enforcement and emerging use of AI in reviews, with the agency emphasizing continued human accountability and efforts to improve transparency and process tracking.

QHub Insights║1 Year After Layoffs, FDA Stable but Faces Long Road to Rebuild Lost Expertise, Says Device Center Vet

One year after RIFs, the FDA has stabilized operationally but faces a prolonged challenge in rebuilding lost institutional knowledge and expertise, according to former official (and current QualityHub VP) Sean Boyd. While review performance remains strong and recovery efforts are underway, gaps in leadership, training, and experience will likely take years to fully address. Meanwhile, the departure of seasoned staff may be benefiting the broader medical device industry, as former regulators bring valuable insight into private-sector roles.

QualityHub Taps Former Zimmer Biomet, Baxter Healthcare Leader Christina Arnt as VP, Medical Device Compliance

QualityHub has appointed medical device quality executive Christina Arnt as Vice President of Medical Device Compliance. Arnt brings extensive global quality systems leadership experience from roles at Zimmer Biomet, Baxter Healthcare, and St. Jude Medical. At QualityHub, she’ll support manufacturers in strengthening regulatory readiness and improving compliance with FDA and global requirements.

Medical Device Inspections: 6 Questions Answered By FDA

The US FDA described in a Town Hall webinar how medical device inspections under the Quality Management System Regulation (QMSR) emphasize a flexible, risk-based approach focused on real-world evidence of compliance across the product lifecycle. Agency investigators will prioritize documentation such as risk management files, training effectiveness, and decision-making practices, while also assessing whether company leadership fosters a genuine Culture of Quality embedded in everyday operations, just to name a few inspectional activities.

Beyond Compliance: The New Playbook for Risk, Supplier Control, and Expertise in MedTech

A QualityHub SME says medical device companies must move beyond treating risk management as a compliance exercise and instead adopt dynamic, continuously updated approaches informed by cross-industry best practices. As outsourcing grows, leading firms are strengthening supplier controls by focusing on process capability and part-specific validation rather than relying solely on audits and inspections.

No April Fooling: 3 Must-Know Things From FDA’s Town Hall on Medical Device Inspections

At an April 1 Town Hall, the US Food and Drug Administration outlined updates to its medical device inspection approach under the Quality Management System Regulation. The changes made to Compliance Program Manual 7382.850 clarify expectations for investigators and give the MedTech industry insight into how facility inspections will be conducted moving forward.

Game On: Eileen Clinton Brings Team Spirit to QualityHub Recruiting

QualityHub has enhanced its recruiting capabilities with the addition of Eileen Clinton as Senior Technical Recruiter, leveraging her athletic teamwork experience and proven talent-sourcing skills to strengthen the consultancy’s pipeline of consultants, SMEs, and other industry professionals.